Klingler H Christoph, Susani Martin, Seip Ralf, Mauermann Julian, Sanghvi Naren, Marberger Michael J
Department of Urology and Pathology, Medical University of Vienna, Vienna, Austria.
Eur Urol. 2008 Apr;53(4):810-6; discussion 817-8. doi: 10.1016/j.eururo.2007.11.020. Epub 2007 Nov 20.
High-intensity focused ultrasound (HIFU) permits targeted homogeneous ablation of tissue. The objective of this phase 1 study was to evaluate the feasibility of HIFU ablation of small renal tumours under laparoscopic control.
Ten kidneys with solitary renal tumours were treated with a newly developed 4.0 MHz laparoscopic HIFU probe. In the first two patients with 9-cm tumours, a defined marker lesion was placed prior to laparoscopic radical nephrectomy. In eight patients with a mean tumour size of 22 mm (range, 11-40), the tumour was completely ablated as in curative intent, followed by laparoscopic partial nephrectomy in seven tumours. One patient had post-HIFU biopsies and was followed radiologically. Specimens were studied by detailed and whole-mount histology, including NADH stains.
Mean HIFU insonication time was 19 min (range, 8-42), with a mean targeted volume of 10.2 cm3 (range, 9-23). At histological evaluation both marker lesions showed irreversible and homogeneous thermal damage within the targeted site. Of the seven tumours treated and removed after HIFU, four showed complete ablation of the entire tumour. Two had a 1- to 3-mm rim of viable tissue immediately adjacent to where the HIFU probe was approximated, and one tumour showed a central area with about 20% vital tissue. There were no intra- or postoperative complications related to HIFU.
The morbidity of laparoscopic partial nephrectomy mainly comes from the need to incise highly vascularized parenchyma. Targeted laparoscopic HIFU ablation may render this unnecessary, but further studies to refine the technique are needed.
高强度聚焦超声(HIFU)可实现对组织的靶向性均匀消融。本1期研究的目的是评估在腹腔镜控制下使用HIFU消融小肾肿瘤的可行性。
对10例患有孤立性肾肿瘤的肾脏使用新开发的4.0 MHz腹腔镜HIFU探头进行治疗。在前两名患有9 cm肿瘤的患者中,在腹腔镜根治性肾切除术之前放置了一个明确的标记性病变。在8例平均肿瘤大小为22 mm(范围11 - 40 mm)的患者中,按治愈意图将肿瘤完全消融,随后对7个肿瘤进行了腹腔镜部分肾切除术。1例患者在HIFU治疗后进行了活检,并接受影像学随访。通过详细的全层组织学检查,包括NADH染色,对标本进行研究。
HIFU平均照射时间为19分钟(范围8 - 42分钟),平均靶向体积为10.2 cm³(范围9 - 23 cm³)。组织学评估显示,两个标记性病变在靶向部位均显示出不可逆的均匀热损伤。在HIFU治疗并切除的7个肿瘤中,4个显示整个肿瘤完全消融。2个在紧邻HIFU探头接触部位有1至3 mm的存活组织边缘,1个肿瘤显示中央区域有大约20%的存活组织。没有与HIFU相关的术中或术后并发症。
腹腔镜部分肾切除术的发病率主要源于需要切开血管丰富的实质。靶向性腹腔镜HIFU消融可能无需如此,但需要进一步研究以完善该技术。